It's really bad, and a lot of us are hurting, but I am glad we can trace the cause to manipulation. We all know it exists. The question then becomes whether to sell or hold, assuming one believes that the technology is sound. I will hold at least until the next filing, when I hope things will be made more clear, especially the financial situation. I don't think we will lose everything, though we do have to face the possibility of a buyout.
Whatever happed to the ideas of using RECAF to monitor existing patients and to keep track of as individual's RECAF levels as an individual diagnostic tool, much as doctors track cholesterol? Does anyone still think these are viable options to consider?